Perspectives of Repeat Drink-drivers in the UK
Dr Andrea Mohan (University of Dundee) presented: "What can we learn from the perspectives of repeat drink-drivers? Findings from a qualitative study".
Practice
HepHIV 2021
The next HepHIV conference will take place 5-7 May 2021 involving participants from across the community, public health and the health system. Due to the COVID-19 pandemic, the HepHIV2021 Lisbon Conference will take place via a virtual platform. A Portuguese national meeting will be arranged if feasible.
Updated HIV Clinical and Service Delivery Recommendations
In late 2020, WHO developed new clinical and service delivery recommendations on key topic areas outlined in the agenda below. To launch and discuss these recommendations, WHO will host a webinar with a brief question and answer session, open to all participants.
Provisional agenda
Director’s Welcome - Department of Global HIV, Hepatitis and Sexually Transmitted Infection Programmes
The Developing Brain with Dr Ruben Baler
Mentor Foundation USA is hosting the webinar The Developing Brain with Dr Ruben Baler
Sixty-fourth session of the Commission on Narcotic Drugs (CND)
The sixty-fourth session of the Commission on Narcotic Drugs will be held from 12 to 16 April 2021.
EU HCV Elimination Policy Summit
Despite the progress that has been made in recent years, HCV remains a major public health problem in Europe. In the European Union (EU) more people die each year from HCV than from HIV/AIDS.
International Approaches to Drug Law Reform
This paper reviews the international evidence on approaches to drug law reform, focussing on case studies from Australia, Canada, Denmark, Portugal and The Netherlands. It seeks to support the ongoing development of innovative approaches to...
Alcohol-Related Violence and Deprivation
Scottish Health Action on Alcohol Problems (SHAAP) and Scottish Alcohol Research Network (SARN) warmly invite you to join us online on Tuesday 30 March from 12:30-14:00 BST for our third SHAAP/SARN Alcohol Occasionals event of 2021.
Dr Carly Lightowlers and Lucy Bryant will present their complementary research and we will then open to Q+A and wider discussion.
A US national randomized study to guide how best to reduce stigma when describing drug‐related impairment in practice and policy
Drug‐related impairment is persistently stigmatized delaying and preventing treatment engagement. To reduce stigma, various medical terms (e.g. ‘chronically relapsing brain disease’, ‘disorder’) have been promoted in diagnostic systems and among national health agencies, yet some argue that over‐medicalization of drug‐related impairment lowers prognostic optimism and reduces personal agency.
National Release of 'Listen First' in Slovenia
‘Listen First’ and ‘The Science of Care’ materials have been translated into Slovenian and are being released nationally in Slovenia by the Institute for Research and Development (UTRIP) through its ‘Prevention Platform’ programme, which is...
